Acumen Pharmaceuticals reported cash from operations of -$18.07M and free cash flow of -$18.07M for the quarter ended Jun 2026, up 43.2% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | -3.94M | -8.35M | -9.13M | -10.15M | -10.71M | -12.86M | -11.30M | -11.59M | -12.91M | -15.12M | -14.77M | -21.57M | -29.79M | -37.64M | -28.92M | -40.78M | -25.94M | -24.96M | -21.15M | -32.54M | |||||
| Share-based Compensation | 0.30M | 0.36M | 0.62M | 0.71M | 0.84M | 0.89M | 1.39M | 1.52M | 1.60M | 1.63M | 2.48M | 2.47M | 2.34M | 2.34M | 2.47M | 2.50M | 2.46M | 2.42M | 2.40M | 2.52M | |||||
| Cash from Operations | -7.69M | -3.64M | -8.30M | -6.47M | -9.18M | -11.20M | -10.18M | -11.67M | -12.90M | -8.31M | -17.86M | -16.55M | -24.60M | -27.21M | -34.12M | -31.83M | -30.49M | -19.10M | -24.13M | -18.07M | |||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.16M | -0.22M | -0.17M | -0.19M | 0.09M | 0.33M | 0.30M | 0.71M | 1.78M | 1.76M | 1.46M | 1.38M | 0.42M | 0.59M | 0.06M | 0.28M | -0.11M | 0.03M | 0.13M | ||||||
| Change in Working Capital | |||||||||||||||||||||||||
| Change in Account Payables | -0.89M | 0.71M | 0.12M | 0.46M | 0.42M | -0.44M | -0.88M | 1.26M | -0.66M | 0.02M | 1.70M | 1.12M | -1.86M | 3.31M | -4.59M | 1.05M | -1.42M | -0.13M | 1.05M | 11.78M | |||||
| Change in Accured Expenses | -0.01M | 2.80M | -1.76M | 0.33M | 0.37M | 0.50M | -0.60M | -0.41M | 0.83M | 3.06M | -3.53M | 1.15M | 0.89M | 1.52M | 0.06M | 4.90M | -3.90M | 2.23M | -5.04M | 2.50M | |||||
| Other Working Capital Changes | 3.19M | -0.42M | -1.42M | -1.87M | 1.22M | 0.36M | 0.90M | 1.03M | -1.50M | -0.07M | 0.23M | 3.12M | 0.85M | -0.54M | -0.95M | -0.76M | 0.51M | -0.16M | -0.69M | 0.62M | |||||
| Investing Activities | |||||||||||||||||||||||||
| Capital Expenditures | 0.01M | 0.03M | 0.01M | 0.04M | 0.08M | 0.04M | 0.01M | 0.01M | 0.08M | -0.06M | 0.08M | 0.01M | |||||||||||||
| Change in Acquisitions & Divestments | 4.00M | 11.86M | 56.00M | 9.00M | 10.20M | 11.06M | 34.73M | 22.98M | 36.10M | 49.51M | 88.41M | 44.76M | 63.82M | 41.50M | 40.51M | 26.25M | 27.02M | 26.00M | |||||||
| Cash from Investing Activities | -94.10M | -10.01M | -5.10M | 8.79M | 55.92M | -20.42M | -41.93M | 11.06M | -92.00M | -48.81M | -9.20M | 37.70M | -10.13M | 29.66M | 28.69M | 38.48M | 40.51M | 26.25M | -13.81M | 26.00M | |||||
| Financing Activities | |||||||||||||||||||||||||
| Other financing activities | 167.31M | -167.94M | 0.00M | 0.10M | 0.33M | 0.15M | 0.04M | 0.00M | 35.75M | -0.30M | |||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 138.53M | -0.00M | 3.79M | 122.29M | -0.39M | 7.94M | |||||||||||||||||||
| Misc. | |||||||||||||||||||||||||
| Cash from Financing Activities | 168.78M | 0.01M | -0.26M | 4.18M | -0.14M | 122.76M | 29.13M | 7.11M | -0.13M | -0.04M | -0.01M | -0.04M | 0.00M | 35.74M | -0.28M | ||||||||||
| Change in Cash | 66.99M | -13.64M | -13.40M | 2.30M | 46.47M | -27.44M | -52.10M | -0.75M | 17.86M | -27.99M | -19.95M | 21.03M | -34.77M | 2.44M | -5.47M | 6.65M | 10.02M | 7.16M | -2.19M | 7.65M | |||||
| Free Cash Flow | -7.70M | -3.67M | -8.31M | -6.50M | -9.26M | -11.24M | -10.18M | -11.67M | -12.91M | -8.33M | -17.94M | -16.48M | -24.60M | -27.21M | -34.20M | -31.84M | -30.49M | -19.10M | -24.13M | -18.07M | |||||
| Net Cash Flow | 66.99M | -13.64M | -13.40M | 2.32M | 46.47M | -27.44M | -52.10M | -0.75M | 17.86M | -27.99M | -19.95M | 21.03M | -34.77M | 2.44M | -5.47M | 6.65M | 10.02M | 7.16M | -2.19M | 7.65M |